Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent

被引:83
作者
Mukhopadhyay, S [1 ]
Chapnick, BM [1 ]
Howlett, AC [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2002年 / 282卷 / 06期
关键词
cannabinoid receptors; vanilloid receptors; pertussis toxin; endothelium; nitric oxide;
D O I
10.1152/ajpheart.00497.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endogenous cannabinoid anandamide (arachidonylethanolamide) produces vasorelaxation in different vascular beds. In the present study, we found that anandamide and a metabolically stable analog, methanandamide, produced dose-dependent (10 nM-10 muM) vasorelaxation of similar to80% in a rabbit aortic ring preparation in an endothelium-dependent manner. Non-endothelium-dependent vasorelaxation was observed to be a maximum of 20-22% at >10 muM methanandamide. The efficacious CB1 receptor analogs desacetyllevonantradol (10 muM) and WIN55212-2 (10 muM) failed to produce vasorelaxation; however, the endothelium-dependent vasorelaxation evoked by methanandamide was partially (75%) blocked by the CB1 receptor antagonist SR141716A. The VR1 vanilloid receptor antagonist capsazepine or the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8-37) partially attenuated (25%) the vasorelaxation in endothelium-intact preparations and greatly reduced the response in endothelium-denuded preparations. Pretreatment of aortic rings with N-G-nitro-L-arginine methyl ester completely blocked the methanandamide-, capsaicin-, and CGRP- induced vasorelaxation. Pretreatment of aortic rings with pertussis toxin attenuated the methanandamide-induced vasorelaxation in endothelium-intact aortic rings, indicating the involvement of G(i/o) proteins in the vasorelaxation; however, pertussis toxin treatment failed to block the endothelium-independent response. Thus, in the rabbit aorta, methanandamide- induced vasorelaxation exhibits two components: 1) in endothelium-intact rings, an SR141716A-sensitive, non-CB1 receptor component that requires pertussis toxin-sensitive G proteins and nitric oxide (NO) production; and 2) in endothelium-denuded rings, a component that is mediated by VR1 vanilloid receptors and possibly by the subsequent release of CGRP that requires NO production but is independent of pertussis toxin-sensitive G proteins.
引用
收藏
页码:H2046 / H2054
页数:9
相关论文
共 46 条
  • [31] N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor
    Pratt, PF
    Hillard, CJ
    Edgemond, WS
    Campbell, WB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (01): : H375 - H381
  • [32] Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation
    Randall, MD
    Kendall, DA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) : 205 - 209
  • [33] An endogenous cannabinoid as an endothelium-derived vasorelaxant
    Randall, MD
    Alexander, SPH
    Bennett, T
    Boyd, EA
    Fry, JR
    Gardiner, SM
    Kemp, PA
    McCulloch, AI
    Kendall, DA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (01) : 114 - 120
  • [34] Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery
    Randall, MD
    McCulloch, AI
    Kendall, DA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (2-3) : 191 - 197
  • [35] SAITO A, 1989, J PHARMACOL EXP THER, V248, P455
  • [36] CGRP ENHANCES INDUCTION OF NO SYNTHASE IN VASCULAR SMOOTH-MUSCLE CELLS VIA A CAMP-DEPENDENT MECHANISM
    SCHINIKERTH, VB
    FISSLTHALER, B
    BUSSE, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1994, 267 (06): : H2483 - H2490
  • [37] Antagonism of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase
    Stefano, GB
    Salzet, M
    Magazine, HI
    Bilfinger, TV
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (06) : 813 - 820
  • [38] NOVEL ANTAGONIST IMPLICATES THE CB1 CANNABINOID RECEPTOR IN THE HYPOTENSIVE ACTION OF ANANDAMIDE
    VARGA, K
    LAKE, K
    MARTIN, BR
    KUNOS, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (03) : 279 - 283
  • [39] Mechanism of the hypotensive action of anandamide in anesthetized rats
    Varga, K
    Lake, KD
    Huangfu, DH
    Guyenet, PG
    Kunos, G
    [J]. HYPERTENSION, 1996, 28 (04) : 682 - 686
  • [40] Cardiovascular actions of cannabinoids and their generation during shock
    Wagner, JA
    Varga, K
    Kunos, G
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (12): : 824 - 836